D

DiagnaMed Holdings Corp
CNSX:DMED

Watchlist Manager
DiagnaMed Holdings Corp
CNSX:DMED
Watchlist
Price: 0.1 CAD 11.11% Market Closed
Market Cap: CA$11.4m

DiagnaMed Holdings Corp
Investor Relations

DiagnaMed Holdings Corp. is a biotechnology company, which engages in the development and commercialization of digital therapeutics for mental health and neurological disorders. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-11-08. The firm is developing a platform of software-based prescription digital therapeutic products (PDT Products) for detecting brain age and tremors for neurological disorders. Its PDT products include BrainYear and BrainTremor. BrainYear is an electroencephalogram-based (EEG) machine-learning solution to detect an individual’s brain age for use in clinic and at-home. BrainTremor is a wearable device to detect tremors and brain activity for neurological disorders by EEG. The firm is also conducting research and development of digital therapeutics applications with the intent to commercialize its PDT Products in the United States. The company also outsources its research and development in the United States and Canada.

Show more
Loading
DMED
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Fabio Chianelli
Chairman, President & CEO
No Bio Available
Mr. Jing Peng C.A., CPA, CA, CPA, MMPA
Chief Financial Officer
No Bio Available
Mr. Andrew Newbury CPA
Corporate Secretary
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
Suite 2900, 550 Burrard Street
Contacts
+17786834324
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett